Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+43.8%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.19 | -96.1% |
| 2023 | 4.85 | +865.8% |
| 2022 | 0.50 | +686.5% |
| 2021 | 0.06 | -16.2% |
| 2020 | 0.08 | +106.1% |
| 2019 | -1.26 | -986.2% |
| 2018 | 0.14 | - |